Eastern Maine Healthcare Systems Inland Hospital

Eastern Maine Healthcare Systems Inland Hospital was paid $18.30M by Medicaid between Jan 2018 and Dec 2024, across 342 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 30% of everything it billed.

33Billing provider infoEASTERN MAINE HEALTHCARE SYSTEMS INLAND HOSPITAL
WATERVILLE, ME 04901

33aNPI1376579557assigned 06/23/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$18.30M

24GClaims696,669

24DCodes billed342

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Maine

Rank by total paid#11 of 33

Median peer was paid$4.34M

This provider vs. median4.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	87,100	$1.85M
2019	98,600	$2.19M
2020	94,153	$2.05M
2021	111,722	$2.94M
2022	106,019	$2.88M
2023	108,502	$3.11M
2024incomplete	90,573	$3.27M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	30%	94,586	75,772	$5.58M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.7%	9,545	8,721	$1.58M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	8.2%	13,001	11,941	$1.50M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	6.4%	31,705	29,414	$1.17M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.8%	4,657	4,227	$1.06M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	3.9%	28,908	26,358	$722K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.5%	4,891	4,365	$456K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	2.1%	6,772	6,349	$387K
76819	Fetal biophysical profile; without non-stress testing	2.0%	6,905	4,115	$373K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.0%	20,844	6,430	$372K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.9%	3,381	3,152	$353K
74177	Computed tomography, abdomen and pelvis; with contrast material	1.6%	2,017	1,896	$300K

330 more codes

96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.4%	3,576	$259K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.3%	3,281	$230K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	7,183	$169K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	3,215	$162K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	9,827	$137K
71046	Radiologic examination, chest; 2 views	<1%	3,804	$133K
96361	Intravenous infusion, hydration; each additional hour	<1%	3,650	$131K
96375	Therapeutic injection; each additional sequential IV push	<1%	4,182	$130K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	5,255	$122K
70450	Computed tomography, head or brain; without contrast material	<1%	1,822	$105K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,008	$102K
99215	Doctor's office visit, returning patient (complex)	<1%	1,964	$85K
80061	Lipid panel	<1%	11,790	$83K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	811	$79K
97597		<1%	2,422	$78K
90837	Psychotherapy session, about an hour	<1%	749	$77K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	5,097	$74K
98928		<1%	6,519	$73K
76830	Ultrasound, transvaginal	<1%	1,006	$70K
80053	Comprehensive metabolic panel	<1%	30,076	$69K
97162		<1%	2,050	$66K
84443	Thyroid stimulating hormone (TSH)	<1%	12,331	$66K
71045	Radiologic examination, chest; single view	<1%	2,157	$64K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	996	$60K
Q3014	Telehealth originating site facility fee	<1%	4,906	$57K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,824	$56K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	165	$51K
20610		<1%	859	$50K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	5,858	$50K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,995	$48K
86900		<1%	1,417	$47K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,879	$47K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,979	$45K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	578	$45K
11721		<1%	5,569	$45K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	29,677	$44K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	362	$40K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,893	$38K
97014		<1%	3,120	$38K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,881	$36K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	356	$35K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	556	$34K
90677		<1%	360	$34K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	8,565	$31K
83036	Hemoglobin; glycosylated (A1C)	<1%	11,069	$30K
99204	Doctor's office visit, new patient (more involved)	<1%	516	$30K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,401	$29K
36415	Collection of venous blood by venipuncture	<1%	36,897	$27K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	11,515	$25K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	531	$23K
90832	Psychotherapy session, about 30 minutes	<1%	614	$23K
98927		<1%	2,259	$22K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	189	$21K
76801		<1%	290	$21K
99203	Doctor's office visit, new patient (routine)	<1%	704	$21K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	264	$18K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	2,434	$18K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	246	$17K
99205	Prolong outpt/office vis	<1%	212	$16K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	195	$15K
99406		<1%	1,609	$15K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	147	$14K
97035		<1%	3,324	$14K
82728		<1%	2,662	$13K
76000		<1%	104	$12K
87088		<1%	7,075	$12K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	28	$12K
90686		<1%	1,331	$12K
82607		<1%	2,512	$11K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	258	$11K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	222	$11K
0012A		<1%	538	$11K
96415		<1%	317	$11K
73630		<1%	1,519	$11K
99443		<1%	437	$10K
84702		<1%	1,633	$10K
84439		<1%	2,741	$10K
0011A		<1%	558	$10K
71271		<1%	179	$9K
98929		<1%	531	$9K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	335	$9K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	940	$8K
90658		<1%	960	$8K
93017		<1%	440	$8K
71275	Computed tomographic angiography, chest, with contrast material	<1%	98	$8K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	352	$8K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	115	$8K
96127		<1%	1,133	$8K
80048	Basic metabolic panel (calcium, ionized)	<1%	6,028	$8K
87081		<1%	3,141	$8K
73030		<1%	651	$7K
83735		<1%	7,612	$7K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	125	$7K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	26	$7K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,344	$7K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	29	$7K
80306		<1%	1,862	$6K
73564		<1%	443	$6K
85027		<1%	3,074	$6K
83550		<1%	2,199	$6K
83540		<1%	2,471	$6K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	228	$5K
95251		<1%	459	$5K
86592		<1%	1,561	$5K
72100		<1%	278	$5K
87631		<1%	1,881	$5K
95250		<1%	110	$5K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	72	$5K
97161		<1%	140	$5K
87390		<1%	1,159	$4K
87077		<1%	3,205	$4K
86140		<1%	3,625	$4K
86803		<1%	1,730	$4K
73130		<1%	615	$4K
G0008	Administration of influenza virus vaccine	<1%	1,167	$4K
64450		<1%	14	$4K
99490	Ccm add 20min	<1%	101	$4K
73610		<1%	377	$3K
86618		<1%	837	$3K
82043		<1%	2,231	$3K
93225		<1%	124	$3K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	12	$3K
0064A		<1%	235	$3K
87186		<1%	1,785	$3K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	110	$3K
82950		<1%	751	$3K
82746		<1%	661	$3K
73502		<1%	258	$3K
76642		<1%	65	$3K
81025		<1%	4,604	$3K
0124A		<1%	230	$3K
86702		<1%	1,162	$3K
85652		<1%	3,500	$3K
97802		<1%	52	$2K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	282	$2K
93971		<1%	53	$2K
71250		<1%	52	$2K
85610		<1%	3,666	$2K
91322		<1%	36	$2K
87205		<1%	2,201	$2K
86701		<1%	1,165	$2K
90656		<1%	165	$2K
86765		<1%	1,111	$2K
83880		<1%	850	$2K
86787		<1%	1,044	$2K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	492	$2K
81003		<1%	8,132	$2K
90791	Psychiatric diagnostic evaluation	<1%	56	$2K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	65	$2K
99442		<1%	147	$2K
80055		<1%	73	$2K
83690		<1%	4,025	$2K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	1,050	$2K
59025	Fetal non-stress test	<1%	16	$1K
76536		<1%	24	$1K
72110		<1%	68	$1K
93226		<1%	167	$1K
82570		<1%	700	$1K
80076		<1%	670	$1K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,655	$1K
94060		<1%	14	$1K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	200	$1K
87469		<1%	187	$1K
81001		<1%	3,868	$1K
87340		<1%	1,186	$1K
77080		<1%	37	$1K
87468		<1%	175	$1K
87484		<1%	175	$1K
83970		<1%	93	$1K
98926		<1%	275	$1K
86762		<1%	876	$1K
87070		<1%	1,407	$998.42
90480		<1%	153	$989.03
90670		<1%	98	$981.54
90662		<1%	415	$936.86
0004A		<1%	82	$903.68
0013A		<1%	61	$883.30
86038		<1%	222	$866.63
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	12	$857.60
0054A		<1%	48	$853.02
76942		<1%	120	$840.36
97803		<1%	25	$788.20
99232	Hospital visit by a doctor, follow-up day	<1%	46	$785.71
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	31	$747.42
94664		<1%	185	$734.20
99460		<1%	12	$726.44
90732		<1%	18	$696.00
74018		<1%	41	$693.93
90734		<1%	122	$682.43
84403		<1%	41	$671.06
90674		<1%	39	$654.58
84600		<1%	62	$654.04
83520		<1%	215	$652.45
69209		<1%	60	$635.32
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	341	$550.70
97165		<1%	30	$537.44
91320		<1%	101	$524.40
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	883	$512.23
73562		<1%	65	$491.30
84550		<1%	554	$479.58
0001A		<1%	72	$473.38
73110		<1%	85	$473.28
82947		<1%	183	$445.02
76770		<1%	13	$436.66
82962		<1%	3,062	$436.20
87478		<1%	99	$424.68
86235		<1%	71	$399.76
82565		<1%	423	$377.83
85730		<1%	400	$374.81
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	73	$335.12
84153		<1%	70	$329.83
86430		<1%	270	$308.03
84100		<1%	207	$295.93
93016		<1%	36	$264.23
82550		<1%	239	$247.94
86480		<1%	13	$247.92
0002A		<1%	57	$240.90
72040		<1%	12	$223.45
97163		<1%	12	$221.74
96160		<1%	29	$215.42
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	33	$205.64
99401		<1%	16	$199.68
93018		<1%	37	$184.10
87150		<1%	15	$182.84
86481		<1%	31	$181.65
86901		<1%	1,495	$181.16
86850		<1%	1,282	$173.82
87400		<1%	152	$157.11
0031A		<1%	12	$154.06
83605		<1%	1,173	$146.57
85379		<1%	518	$145.45
96367		<1%	12	$141.70
84484		<1%	3,924	$140.44
80305		<1%	1,072	$120.82
82105		<1%	13	$119.98
99024		<1%	14	$119.45
82150		<1%	80	$110.16
87040		<1%	388	$107.64
86200		<1%	98	$107.05
82784		<1%	12	$98.80
93270		<1%	29	$90.31
72125	Computed tomography, cervical spine; without contrast material	<1%	12	$85.80
84481		<1%	13	$84.70
G0432	Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening	<1%	13	$62.40
84163		<1%	13	$60.56
G0009	Administration of pneumococcal vaccine	<1%	25	$57.89
86706		<1%	14	$53.45
83516		<1%	14	$46.12
99441		<1%	17	$44.98
87210		<1%	63	$43.60
90715		<1%	2,260	$41.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	217	$38.80
90653		<1%	133	$38.00
87075		<1%	25	$37.88
82248		<1%	15	$30.12
83721		<1%	13	$28.11
82310		<1%	26	$26.75
82948		<1%	472	$19.55
86431		<1%	16	$17.01
82077		<1%	297	$15.23
84703		<1%	83	$15.04
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	397	$13.33
82044		<1%	55	$13.04
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	4,970	$5.96
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	15	$5.32
84520		<1%	12	$4.03
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	31	$3.53
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	4,288	$3.25
J7030	Infusion, normal saline solution , 1000 cc	<1%	4,236	$3.04
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	439	$2.04
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	14	$1.65
J7050	Infusion, normal saline solution, 250 cc	<1%	956	$0.96
91301		0%	844	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	750	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	438	$0.00
95886		0%	258	$0.00
J3010	Injection, fentanyl citrate, 0.1 mg	0%	2,462	$0.00
J2250	Injection, midazolam hydrochloride, per 1 mg	0%	1,635	$0.00
J2704	Injection, propofol, 10 mg	0%	2,782	$0.00
96376		0%	658	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	193	$0.00
G0378	Hospital observation service, per hour	0%	631	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	62	$0.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	0%	1,976	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	110	$0.00
G8952	Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given	0%	39	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	89	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	84	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	394	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	582	$0.00
A9270	Non-covered item or service	0%	866	$0.00
Q2036	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)	0%	142	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	141	$0.00
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	0%	38	$0.00
90651		0%	45	$0.00
84132		0%	12	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	17	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	15	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	84	$0.00
94760		0%	154	$0.00
91305		0%	65	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	49	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	18	$0.00
90619		0%	18	$0.00
J2060	Injection, lorazepam, 2 mg	0%	49	$0.00
91306		0%	42	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	13	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	460	$0.00
90472	Immunization administration, each additional vaccine (list separately)	0%	2,031	$0.00
91300		0%	342	$0.00
81401		0%	43	$0.00
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	0%	14	$0.00
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	0%	1,112	$0.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	0%	1,073	$0.00
J2270	Injection, morphine sulfate, up to 10 mg	0%	94	$0.00
91312		0%	120	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	29	$0.00
G0071	Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only	0%	29	$0.00
J7120	Ringers lactate infusion, up to 1000 cc	0%	209	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	26	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	54	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	55	$0.00
94729		0%	14	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	13	$0.00
94727		0%	14	$0.00
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	0%	16	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	26	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	24	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	16	$0.00
90633		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBITHER, DEAN (V.P. FINANCE)